Showing results (121-130 of 2,440) with videos related to
Sort By:
Pageof 244
Advances in Experimental Medicine and Biology|November 17, 2019
Neutrophil Interaction with Emerging Oral Pathogens: A Novel View of the Disease ParadigmIrina Miralda, Aruna Vashishta, Silvia M UriarteIndian Journal of Public Health|September 21, 2017
Regulating smokeless tobacco and processed areca nut in South-East Asia region: The journey so far and the road aheadJagdish Kaur, Thaksaphon Thamarangsi, Arvind Vashishta RinkooIndian Journal of Public Health|September 21, 2017
Using public interest litigation for tobacco control: Insights from IndiaJagdish Kaur, Arvind Vashishta Rinkoo, Ranjit SinghTobacco Control|June 8, 2024
Update on numbers of tobacco-attributable deaths by country in the South-East Asia region: implications for policyJagdish Kaur, Arvind Vashishta Rinkoo, Sol RichardsonCNS & Neurological Disorders Drug Targets|October 15, 2010
Molecular chaperones as rational drug targets for Parkinson's disease therapeuticsS K Kalia, L V Kalia, P J McLeanThe Lancet. Neurology|July 19, 2008
NMDA receptors in clinical neurology: excitatory times aheadLorraine V Kalia, Suneil K Kalia, Michael W SalterBritish Journal of Pharmacology|May 4, 2018
Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's diseaseDarren M O'Hara, Suneil K Kalia, Lorraine V KaliaAnnals of the Royal College of Surgeons of England|July 13, 2006
Toe-tourniquet syndrome: a diagnostic dilemma!Parkash Lohana, Girish N Vashishta, Neil PriceCritical Reviews in Clinical Laboratory Sciences|March 3, 2020
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's diseaseDarren M O'Hara, Suneil K Kalia, Lorraine V KaliaMovement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Disease-modifying strategies for Parkinson's diseaseLorraine V Kalia, Suneil K Kalia, Anthony E LangPageof 244